|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
MARIBAVIR |
J05AX10 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
ACICLOVIR |
J05AB01 |
IT
|
II
|
19-07-2023 |
|
11-02-2002 |
VALID
|
|
BARICITINIB |
L04AF02 |
IT
|
I
|
19-07-2023 |
|
|
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
IT
|
I
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
COMBINATIONS |
N01BB20 |
IT
|
II + Exemption
|
19-07-2023 |
EMEA/H/C/002693 |
15-11-2013 |
VALID
|
|
CYTISINICLINE |
N07BA04 |
IT
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
DIOSMIN |
C05CA03 |
IT
|
Not subject to prescription
|
19-07-2023 |
|
22-08-2003 |
VALID
|
|
MEBEVERINE |
A03AA04 |
IT
|
II
|
19-07-2023 |
|
|
VALID
|
|
PAPAVERINE |
A03AD01 |
IT
|
I + Exemption
|
19-07-2023 |
|
22-08-2003 |
VALID
|
|
SUCRALFATE |
A02BX02 |
IT
|
II
|
19-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
IT
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
ZINC SULFATE |
A12CB01 |
IT
|
II
|
19-07-2023 |
|
22-08-2003 |
VALID
|
|
DABRAFENIB |
L01EC02 |
IT
|
I
|
18-07-2023 |
|
|
VALID
|
|
FERRIC HYDROXIDE |
B03AB04 |
IT
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
FERRIC MALTOL |
B03AB10 |
IT
|
II
|
18-07-2023 |
EMEA/H/C/002733 |
18-02-2016 |
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B03AD03 |
IT
|
II
|
18-07-2023 |
|
|
VALID
|
|
SACCHARATED IRON OXIDE |
B03AB02 |
IT
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
VEMURAFENIB |
L01EC01 |
IT
|
I
|
18-07-2023 |
|
|
VALID
|
|
BOSUTINIB |
L01EA04 |
IT
|
I
|
13-07-2023 |
|
|
VALID
|
|
ERLOTINIB |
L01EB02 |
IT
|
I
|
13-07-2023 |
|
|
VALID
|
|
NILOTINIB |
L01EA03 |
IT
|
I
|
13-07-2023 |
|
|
VALID
|
|
ICATIBANT |
B06AC02 |
IT
|
I
|
12-07-2023 |
|
|
VALID
|
|
ERENUMAB |
N02CD01 |
IT
|
I
|
31-05-2023 |
|
|
VALID
|
|
AZELASTINE |
S01GX07 |
IT
|
Not subject to prescription
|
23-02-2023 |
|
|
VALID
|
|
EMEDASTINE |
S01GX06 |
IT
|
II
|
23-02-2023 |
|
|
VALID
|
|
EPINASTINE |
S01GX10 |
IT
|
Not subject to prescription
|
23-02-2023 |
|
|
VALID
|
|
KETOTIFEN |
S01GX08 |
IT
|
Not subject to prescription
|
23-02-2023 |
|
|
VALID
|
|
LODOXAMIDE |
S01GX05 |
IT
|
Not authorised
|
23-02-2023 |
|
|
VALID
|
|
NEDOCROMIL |
S01GX04 |
IT
|
Not authorised
|
23-02-2023 |
|
|
VALID
|
|
OLOPATADINE |
S01GX09 |
IT
|
Not subject to prescription
|
23-02-2023 |
|
|
VALID
|
|
SPAGLUMIC ACID |
S01GX03 |
IT
|
Not subject to prescription
|
23-02-2023 |
|
|
VALID
|
|
CROMOGLICIC ACID |
S01GX01 |
IT
|
Not subject to prescription
|
21-02-2023 |
|
|
VALID
|
|
PHENYLEPHRINE, COMBINATIONS |
S01GA55 |
IT
|
Not authorised
|
20-02-2023 |
|
|
VALID
|
|
TETRYZOLINE, COMBINATIONS |
S01GA52 |
IT
|
II + Exemption
|
20-02-2023 |
|
|
VALID
|
|
NAPHAZOLINE, COMBINATIONS |
S01GA51 |
IT
|
Not subject to prescription
|
14-02-2023 |
|
22-08-2003 |
VALID
|
|
LIDOCAINE |
D04AB01 |
IT
|
Not subject to prescription
|
25-01-2023 |
|
|
VALID
|
|
NAPHAZOLINE |
S01GA01 |
IT
|
Not subject to prescription
|
25-01-2023 |
|
22-08-2003 |
VALID
|
|
OXYMETAZOLINE |
S01GA04 |
IT
|
Not authorised
|
25-01-2023 |
|
|
VALID
|
|
TETRYZOLINE |
S01GA02 |
IT
|
Not subject to prescription
|
25-01-2023 |
|
22-08-2003 |
VALID
|
|
ASCIMINIB |
L01EA06 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
